AI Transparency Report
The Lung Cancer Foundation Of America demonstrates a generally healthy financial trajectory, marked by consistent revenue growth and a strong program spending focus. In the latest reported period (202312), the organization generated $2,265,637 in revenue against $1,854,172 in expenses, indicating a surplus that contributes to asset growth. Over the past five years, revenue has more than doubled from $1,003,191 in 201912 to $2,265,637 in 202312, showcasing robust fundraising efforts. The organization's assets have also grown significantly, from $1,317,950 in 201912 to $1,548,034 in 202312, providing a solid financial foundation. A key strength is the reported 0% officer compensation across all available filings, which suggests a volunteer-driven leadership or that compensation is not reported in a way that is easily identifiable as 'officer compensation' in the summary data, enhancing its perceived efficiency and donor trust. The NTEE code G12 (Diseases, Disorders, Medical Disciplines) aligns well with its mission, and the consistent growth in assets and revenue, coupled with a lack of reported officer compensation, points to a well-managed and transparent operation.